Posterior reversible encephalopathy syndrome in a woman who used gonadotropin-releasing hormone agonists: a case report

Posterior reversible encephalopathy syndrome (PRES) is a newly described adverse effect possibly associated with gonadotropin-releasing hormone (GnRH) agonist therapy. We report a case of PRES after 2 doses of depot GnRH agonists in a 44-year-old woman with a huge myoma uteri and iron-deficiency ane...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Minhee, Kim, Tae Hee, Kim, Se Jeong, Jee, Byung Chul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Obstetrics and Gynecology; Korean Society of Contraception and Reproductive Health; Korean Society of Gynecologic Endocrinology; Korean Society of Gynecologic Endoscopy and Minimal Invasive Surgery; Korean Society of Maternal Fetal Medicine; Korean Society of Ultrasound in Obstetrics and Gynecology; Korean Urogynecologic Society 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333760/
https://www.ncbi.nlm.nih.gov/pubmed/30671396
http://dx.doi.org/10.5468/ogs.2019.62.1.69

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333760/
https://www.ncbi.nlm.nih.gov/pubmed/30671396
http://dx.doi.org/10.5468/ogs.2019.62.1.69

Ejemplares similares